1. Adelaide Research & Scholarship

Search


Current filters:





Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 10 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2005Effect of psychiatry liaison with general practitioners on depression severity in recently hospitalised cardiac patients: a randomised controlled trialSchrader, G.; Cheok, F.; Hordacre, A.; Marker, J.; Wade, V.
2005Revision dacryocystorhinostomy: a comparison of endoscopic and external techniquesTsirbas, A.; Davis, G.; Wormald, P.
2005Short-term outcomes of five heroin detoxification methods in the Australian NEPOD projectDigiusto, E.; Lintzeris, N.; Breen, C.; Kimber, J.; Mattick, R.; Bell, J.; Ali, R.; Saunders, J.
2005Superior outcomes in renal transplantation after early cyclosporine withdrawal and sirolimus maintenance therapy, regardless of baseline renal functionRuss, G.; Segoloni, G.; Oberbauer, R.; Legendre, C.; Mota, A.; Eris, J.; Grinyo, J.; Friend, P.; Lawen, J.; Hartmann, A.; Schena, F.; Lelong, M.; Burke, J.; Neylan, J.
2005Microcystic adnexal carcinoma: Treatment with Mohs micrographic surgeryLeibovitch, I.; Huilgol, S.; Selva-Nayagam, D.; Lun, K.; Richards, S.; Paver, R.
2005Basal cell carcinoma treated with Mohs surgery in Australia - II. Outcome at 5-year follow-upLeibovitch, I.; Huilgol, S.; Selva-Nayagam, D.; Richards, S.; Paver, R.
2005Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS)Darke, S.; Ross, J.; Teesson, M.; Ali, R.; Cooke, R.; Ritter, A.; Lynskey, M.
2005Enzyme replacement therapy for Gaucher disease in AustraliaGoldblatt, J.; Szer, J.; Fletcher, J.; McGill, J.; Rowell, J.; Wilson, M.
2005Emergency neurosurgery by general surgeons at a remote major hospitalTreacy, J.; Reilly, P.; Brophy, B.
2005Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human n-acetylgalactosamine 4-sulfataseHarmatz, P.; Ketteridge, D.; Giugliani, R.; Guffon, N.; Teles, E.; Miranda, C.; Yu, Z.; Swiedler, S.; Hopwood, J.

Discover